Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Colorcon
McKinsey
Harvard Business School
Dow

Last Updated: February 7, 2023

CLINICAL TRIALS PROFILE FOR METHOCARBAMOL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Methocarbamol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02432456 ↗ Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients Completed Medical College of Wisconsin Phase 4 2015-09-01 This study will evaluate the effectiveness of ketamine infusions in the management of acute pain resulting from broken ribs suffered following a blunt trauma. Half of patients will receive the institutional standard of care and a placebo infusion (no active medication). The other half of patients will receive the institutional standard of care and a ketamine infusion. All subjects and staff will be blinded as to whether they are receiving placebo or ketamine.
NCT02642874 ↗ Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients Unknown status Tanta University Phase 3 2017-04-01 Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.
NCT02665286 ↗ Orphenadrine and Methocarbamol for LBP Completed Montefiore Medical Center Phase 4 2016-03-01 Low back pain is a common cause of visit to emergency department. It is not clear if skeletal muscle relaxants are of benefit for patients with acute low back pain. This is a randomized study to determine if skeletal muscle relaxants, when combined with naproxen, improve outcomes more than naproxen alone
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Methocarbamol

Condition Name

Condition Name for Methocarbamol
Intervention Trials
Low Back Pain 2
Rib Fractures 1
Fractures, Bone 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Methocarbamol
Intervention Trials
Low Back Pain 2
Fractures, Bone 2
Back Pain 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Methocarbamol

Trials by Country

Trials by Country for Methocarbamol
Location Trials
United States 5
Italy 2
Japan 1
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Methocarbamol
Location Trials
New York 1
Wisconsin 1
Illinois 1
Minnesota 1
West Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Methocarbamol

Clinical Trial Phase

Clinical Trial Phase for Methocarbamol
Clinical Trial Phase Trials
Phase 4 6
Phase 3 3
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Methocarbamol
Clinical Trial Phase Trials
Completed 3
Not yet recruiting 3
Recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Methocarbamol

Sponsor Name

Sponsor Name for Methocarbamol
Sponsor Trials
Medical College of Wisconsin 1
Prisma Health-Upstate 1
Tanta University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Methocarbamol
Sponsor Trials
Other 11
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Dow
Merck
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.